TAVABOROLE
- Product NDC
- 51672-1397
- 11-digit product format
- 516721397
- Labeler code
- 51672
- Product ID
- 51672-1397_34940f27-ae26-41f3-9544-bd9d500fa85c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- TAVABOROLE
- Dosage form
- SOLUTION
- Route
- TOPICAL
- Labeler
- Taro Pharmaceuticals U.S.A., Inc.
- Application
- ANDA212215
- Marketing category
- ANDA
- Marketing start
- 2021-05-07
- Marketing end
- 0000-00-00
- Substance
- TAVABOROLE
- Active strength
- 44 mg/mL
- Pharmacologic classes
- Oxaborole Antifungal [EPC],Protein Synthesis Inhibitors [MoA],Boron Compounds [CS]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 51672-1397 | TAVABOROLE SOLUTION [TARO PHARMACEUTICALS U.S.A., INC.] | 3 | Legacy NDC | 20210514_bb502849-12d5-432a-aac2-e4bc0407db3d.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 51672-1397-9 | 51672139709 | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (51672-1397-9) > 10 mL in 1 BOTTLE, WITH APPLICATOR | 2021-05-07 | 0000-00-00 | No | No | Current |